An evaluation of a multiplex PCR assay for the detection of Treponema pallidum, HSV-1, and HSV-2

Diagn Microbiol Infect Dis. 2023 Apr 19;106(3):115958. doi: 10.1016/j.diagmicrobio.2023.115958. Online ahead of print.ABSTRACTMultiplex PCR can utilize limited clinical material and is more cost-effective and expected to be used for the detection of Treponema pallidum, herpes simplex virus type 1 and 2 (HSV-1,2). We established a multiplex TP-HSV1-HSV2 Polymerase Chain Reaction (multiplex PCR) targeting the conserved regions of the PolA gene of TP and the UL42 gene of HSV1 and HSV2 to test skin lesions of 115 patients suspected of having TP and HSV1/2 infections. The laboratory sensitivities for all 3 pathogens were 300 copies/mL. The overall clinical sensitivity and specificity in secretion samples for TP were 91.7% and 100%, for HSV1 100% and 98%, and for HSV2 89.7% and 100%, respectively. The method appears superior in patients suspected of early TP infection but negative for nontreponemal antibody testing, and the method is also useful for the differential diagnosis of new skin lesions on genital, perianal, and oral sites of patients with a history of previous syphilis.PMID:37172529 | DOI:10.1016/j.diagmicrobio.2023.115958
Source: Herpes - Category: Infectious Diseases Authors: Source Type: research